Global and United States Tuberculosis Vaccines Market Insights, Forecast to 2026

Publisher Name :
Date: 23-Oct-2020
No. of pages: 133
Inquire Before Buying

Tuberculosis Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Tuberculosis Vaccines market is segmented into

- Immunotherapeutic Vaccines

- Booster Vaccines

- Others

Segment by Application, the Tuberculosis Vaccines market is segmented into

- Hospitals

- Clinics

- Others

Regional and Country-level Analysis

The Tuberculosis Vaccines market is analysed and market size information is provided by regions (countries).

The key regions covered in the Tuberculosis Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Tuberculosis Vaccines Market Share Analysis

Tuberculosis Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tuberculosis Vaccines business, the date to enter into the Tuberculosis Vaccines market, Tuberculosis Vaccines product introduction, recent developments, etc.

The major vendors covered:

- Sanofi

- Merck

- Serum Institute of India

- GlaxoSmithKline

- Japan BCG Lab

- IDT Biologics

- GreenSignal Bio Pharma

- Taj Pharmaceuticals

- Bavarian Nordic

- China National Biotec Group

Global and United States Tuberculosis Vaccines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Tuberculosis Vaccines Product Introduction
1.2 Market Segments
1.3 Key Tuberculosis Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Vaccines Market Size Growth Rate by Type
1.4.2 Immunotherapeutic Vaccines
1.4.3 Booster Vaccines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Tuberculosis Vaccines Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Tuberculosis Vaccines Revenue 2015-2026
2.1.2 Global Tuberculosis Vaccines Sales 2015-2026
2.2 Global Tuberculosis Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Tuberculosis Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Tuberculosis Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Tuberculosis Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Tuberculosis Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Tuberculosis Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Tuberculosis Vaccines Revenue Forecast by Region (2021-2026)
3 Global Tuberculosis Vaccines Competitor Landscape by Players
3.1 Global Top Tuberculosis Vaccines Sales by Manufacturers
3.1.1 Global Tuberculosis Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Tuberculosis Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Tuberculosis Vaccines Manufacturers by Revenue
3.2.1 Global Tuberculosis Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Tuberculosis Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tuberculosis Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tuberculosis Vaccines Revenue in 2019
3.2.5 Global Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Tuberculosis Vaccines Price by Manufacturers
3.4 Global Tuberculosis Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Tuberculosis Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tuberculosis Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Tuberculosis Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Vaccines Market Size by Type (2015-2020)
4.1.1 Global Tuberculosis Vaccines Sales by Type (2015-2020)
4.1.2 Global Tuberculosis Vaccines Revenue by Type (2015-2020)
4.1.3 Tuberculosis Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tuberculosis Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Tuberculosis Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Tuberculosis Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Tuberculosis Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tuberculosis Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Vaccines Market Size by Application (2015-2020)
5.1.1 Global Tuberculosis Vaccines Sales by Application (2015-2020)
5.1.2 Global Tuberculosis Vaccines Revenue by Application (2015-2020)
5.1.3 Tuberculosis Vaccines Price by Application (2015-2020)
5.2 Tuberculosis Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Tuberculosis Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Tuberculosis Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Tuberculosis Vaccines Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Tuberculosis Vaccines Market Size YoY Growth 2015-2026
6.1.1 United States Tuberculosis Vaccines Sales YoY Growth 2015-2026
6.1.2 United States Tuberculosis Vaccines Revenue YoY Growth 2015-2026
6.1.3 United States Tuberculosis Vaccines Market Share in Global Market 2015-2026
6.2 United States Tuberculosis Vaccines Market Size by Players (International and Local Players)
6.2.1 United States Top Tuberculosis Vaccines Players by Sales (2015-2020)
6.2.2 United States Top Tuberculosis Vaccines Players by Revenue (2015-2020)
6.3 United States Tuberculosis Vaccines Historic Market Review by Type (2015-2020)
6.3.1 United States Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
6.3.2 United States Tuberculosis Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 United States Tuberculosis Vaccines Price by Type (2015-2020)
6.4 United States Tuberculosis Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Tuberculosis Vaccines Sales Forecast by Type (2021-2026)
6.4.2 United States Tuberculosis Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 United States Tuberculosis Vaccines Price Forecast by Type (2021-2026)
6.5 United States Tuberculosis Vaccines Historic Market Review by Application (2015-2020)
6.5.1 United States Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
6.5.2 United States Tuberculosis Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 United States Tuberculosis Vaccines Price by Application (2015-2020)
6.6 United States Tuberculosis Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Tuberculosis Vaccines Sales Forecast by Application (2021-2026)
6.6.2 United States Tuberculosis Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 United States Tuberculosis Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Tuberculosis Vaccines Market Size YoY Growth 2015-2026
7.2 North America Tuberculosis Vaccines Market Facts & Figures by Country
7.2.1 North America Tuberculosis Vaccines Sales by Country (2015-2020)
7.2.2 North America Tuberculosis Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Tuberculosis Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Tuberculosis Vaccines Market Facts & Figures by Country
8.2.1 Europe Tuberculosis Vaccines Sales by Country
8.2.2 Europe Tuberculosis Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Tuberculosis Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Tuberculosis Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Tuberculosis Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Tuberculosis Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Tuberculosis Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Tuberculosis Vaccines Market Facts & Figures by Country
10.2.1 Latin America Tuberculosis Vaccines Sales by Country
10.2.2 Latin America Tuberculosis Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tuberculosis Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Tuberculosis Vaccines Sales by Country
11.2.2 Middle East and Africa Tuberculosis Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Description and Business Overview
12.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Tuberculosis Vaccines Products Offered
12.1.5 Sanofi Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Tuberculosis Vaccines Products Offered
12.2.5 Merck Recent Development
12.3 Serum Institute of India
12.3.1 Serum Institute of India Corporation Information
12.3.2 Serum Institute of India Description and Business Overview
12.3.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Serum Institute of India Tuberculosis Vaccines Products Offered
12.3.5 Serum Institute of India Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Description and Business Overview
12.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Tuberculosis Vaccines Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 Japan BCG Lab
12.5.1 Japan BCG Lab Corporation Information
12.5.2 Japan BCG Lab Description and Business Overview
12.5.3 Japan BCG Lab Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Japan BCG Lab Tuberculosis Vaccines Products Offered
12.5.5 Japan BCG Lab Recent Development
12.6 IDT Biologics
12.6.1 IDT Biologics Corporation Information
12.6.2 IDT Biologics Description and Business Overview
12.6.3 IDT Biologics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 IDT Biologics Tuberculosis Vaccines Products Offered
12.6.5 IDT Biologics Recent Development
12.7 GreenSignal Bio Pharma
12.7.1 GreenSignal Bio Pharma Corporation Information
12.7.2 GreenSignal Bio Pharma Description and Business Overview
12.7.3 GreenSignal Bio Pharma Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GreenSignal Bio Pharma Tuberculosis Vaccines Products Offered
12.7.5 GreenSignal Bio Pharma Recent Development
12.8 Taj Pharmaceuticals
12.8.1 Taj Pharmaceuticals Corporation Information
12.8.2 Taj Pharmaceuticals Description and Business Overview
12.8.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Products Offered
12.8.5 Taj Pharmaceuticals Recent Development
12.9 Bavarian Nordic
12.9.1 Bavarian Nordic Corporation Information
12.9.2 Bavarian Nordic Description and Business Overview
12.9.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bavarian Nordic Tuberculosis Vaccines Products Offered
12.9.5 Bavarian Nordic Recent Development
12.10 China National Biotec Group
12.10.1 China National Biotec Group Corporation Information
12.10.2 China National Biotec Group Description and Business Overview
12.10.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
12.10.4 China National Biotec Group Tuberculosis Vaccines Products Offered
12.10.5 China National Biotec Group Recent Development
12.11 Sanofi
12.11.1 Sanofi Corporation Information
12.11.2 Sanofi Description and Business Overview
12.11.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sanofi Tuberculosis Vaccines Products Offered
12.11.5 Sanofi Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Tuberculosis Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tuberculosis Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Tuberculosis Vaccines Market Segments
Table 2. Ranking of Global Top Tuberculosis Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tuberculosis Vaccines Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Immunotherapeutic Vaccines
Table 5. Major Manufacturers of Booster Vaccines
Table 6. Major Manufacturers of Others
Table 7. Global Tuberculosis Vaccines Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Tuberculosis Vaccines Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Tuberculosis Vaccines Sales by Regions 2015-2020 (K Doses)
Table 10. Global Tuberculosis Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Tuberculosis Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Tuberculosis Vaccines Sales Forecast by Region (2021-2026) (K Doses)
Table 13. Global Tuberculosis Vaccines Sales by Manufacturers (2015-2020) (K Doses)
Table 14. Global Tuberculosis Vaccines Sales Share by Manufacturers (2015-2020)
Table 15. Global Tuberculosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Tuberculosis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccines as of 2019)
Table 17. Tuberculosis Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Tuberculosis Vaccines Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Tuberculosis Vaccines Price (2015-2020) (USD/Dose)
Table 20. Tuberculosis Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Tuberculosis Vaccines Product Type
Table 22. Date of International Manufacturers Enter into Tuberculosis Vaccines Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 25. Global Tuberculosis Vaccines Sales Share by Type (2015-2020)
Table 26. Global Tuberculosis Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Tuberculosis Vaccines Revenue Share by Type (2015-2020)
Table 28. Tuberculosis Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 29. Global Tuberculosis Vaccines Sales Share by Type (2021-2026)
Table 30. Global Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 31. Global Tuberculosis Vaccines Sales Share by Application (2015-2020)
Table 32. Global Tuberculosis Vaccines Sales Share by Application (2021-2026)
Table 33. Global Tuberculosis Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Tuberculosis Vaccines Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Tuberculosis Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 36. United States Tuberculosis Vaccines Sales (K Doses) of Key Companies (2015-2020)
Table 37. United States Tuberculosis Vaccines Sales Share by Company (2015-2020)
Table 38. United States Tuberculosis Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 39. United States Tuberculosis Vaccines Sales (K Doses) by Type (2015-2020)
Table 40. United States Tuberculosis Vaccines Sales Share by Type (2015-2020)
Table 41. United States Tuberculosis Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. United States Tuberculosis Vaccines Price (K Doses) by Type (2015-2020)
Table 43. United States Tuberculosis Vaccines Sales (K Doses) by Type (2021-2026)
Table 44. United States Tuberculosis Vaccines Sales Share by Type (2021-2026)
Table 45. United States Tuberculosis Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. United States Tuberculosis Vaccines Revenue Share by Type (2021-2026)
Table 47. United States Tuberculosis Vaccines Price (K Doses) by Type (2021-2026)
Table 48. United States Tuberculosis Vaccines Sales (K Doses) by Application (2015-2020)
Table 49. United States Tuberculosis Vaccines Sales Share by Application (2015-2020)
Table 50. United States Tuberculosis Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. United States Tuberculosis Vaccines Sales (K Doses) by Application (2021-2026)
Table 52. United States Tuberculosis Vaccines Sales Share by Application (2021-2026)
Table 53. United States Tuberculosis Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. United States Tuberculosis Vaccines Revenue Share by Application (2021-2026)
Table 55. North America Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 56. North America Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 57. North America Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 59. Europe Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 60. Europe Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 61. Europe Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Tuberculosis Vaccines Sales by Region (2015-2020) (K Doses)
Table 64. Asia Pacific Tuberculosis Vaccines Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Tuberculosis Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Tuberculosis Vaccines Revenue Market Share by Region (2015-2020)
Table 67. Latin America Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 68. Latin America Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 72. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Sanofi Tuberculosis Vaccines Product
Table 79. Sanofi Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Merck Product
Table 84. Merck Recent Development
Table 85. Serum Institute of India Corporation Information
Table 86. Serum Institute of India Description and Business Overview
Table 87. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Serum Institute of India Product
Table 89. Serum Institute of India Recent Development
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline Product
Table 94. GlaxoSmithKline Recent Development
Table 95. Japan BCG Lab Corporation Information
Table 96. Japan BCG Lab Description and Business Overview
Table 97. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Japan BCG Lab Product
Table 99. Japan BCG Lab Recent Development
Table 100. IDT Biologics Corporation Information
Table 101. IDT Biologics Description and Business Overview
Table 102. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. IDT Biologics Product
Table 104. IDT Biologics Recent Development
Table 105. GreenSignal Bio Pharma Corporation Information
Table 106. GreenSignal Bio Pharma Description and Business Overview
Table 107. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. GreenSignal Bio Pharma Product
Table 109. GreenSignal Bio Pharma Recent Development
Table 110. Taj Pharmaceuticals Corporation Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Taj Pharmaceuticals Product
Table 114. Taj Pharmaceuticals Recent Development
Table 115. Bavarian Nordic Corporation Information
Table 116. Bavarian Nordic Description and Business Overview
Table 117. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. Bavarian Nordic Product
Table 119. Bavarian Nordic Recent Development
Table 120. China National Biotec Group Corporation Information
Table 121. China National Biotec Group Description and Business Overview
Table 122. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. China National Biotec Group Product
Table 124. China National Biotec Group Recent Development
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Tuberculosis Vaccines Players
Table 129. Tuberculosis Vaccines Customers List
Table 130. Tuberculosis Vaccines Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccines Product Picture
Figure 2. Global Tuberculosis Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Immunotherapeutic Vaccines Product Picture
Figure 4. Booster Vaccines Product Picture
Figure 5. Others Product Picture
Figure 6. Global Tuberculosis Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Tuberculosis Vaccines Report Years Considered
Figure 11. Global Tuberculosis Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Tuberculosis Vaccines Sales 2015-2026 (K Doses)
Figure 13. Global Tuberculosis Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Tuberculosis Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Tuberculosis Vaccines Sales Market Share by Region in 2019
Figure 16. Global Tuberculosis Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Tuberculosis Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Tuberculosis Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Tuberculosis Vaccines Revenue in 2019
Figure 20. Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Tuberculosis Vaccines Sales Market Share by Type in 2019
Figure 23. Global Tuberculosis Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Tuberculosis Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Tuberculosis Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Tuberculosis Vaccines Sales Market Share by Application in 2019
Figure 28. Global Tuberculosis Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Tuberculosis Vaccines Revenue Market Share by Application in 2019
Figure 30. United States Tuberculosis Vaccines Sales Growth Rate 2015-2026 (K Doses)
Figure 31. United States Tuberculosis Vaccines Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. United States Tuberculosis Vaccines Market Share in Global Market 2015-2026
Figure 33. United States 5 and 10 Largest Tuberculosis Vaccines Players Market Share by Revenue in Tuberculosis Vaccines in 2019
Figure 34. United States Tuberculosis Vaccines Revenue Share by Type (2015-2020)
Figure 35. United States Tuberculosis Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 36. United States Tuberculosis Vaccines Revenue Share by Application (2015-2020)
Figure 37. United States Tuberculosis Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 39. North America Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 41. North America Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 42. U.S. Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 43. U.S. Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Canada Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 47. Europe Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 49. Europe Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 50. Germany Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Germany Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 53. France Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 55. U.K. Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 59. Russia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 61. Asia Pacific Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Tuberculosis Vaccines Sales Market Share by Region in 2019
Figure 63. Asia Pacific Tuberculosis Vaccines Revenue Market Share by Region in 2019
Figure 64. China Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 65. China Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Japan Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 69. South Korea Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 71. India Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Australia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Taiwan Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Indonesia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Thailand Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Malaysia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 83. Philippines Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 85. Vietnam Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 87. Latin America Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 89. Latin America Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 90. Mexico Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Mexico Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Brazil Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 95. Argentina Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Porter's Five Forces Analysis
Figure 107. Tuberculosis Vaccines Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
  • (Post-pandemic Era) - Global Smoking Cessation Products Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 102
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Keyhole Limpet Hemocyanin (KLH) Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 107
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Erythropoietin Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 103
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Physiological Sea Water Nasal Spray Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 117
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Herbal Oil Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 114
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Excipients Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 104
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Cetrimide Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 107
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Smoking Cessation Products Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 27-Nov-2020        Price: US 3650 Onwards        Pages: 107
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Keyhole Limpet Hemocyanin (KLH) Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 27-Nov-2020        Price: US 3650 Onwards        Pages: 102
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs